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Summary.-The effects of various cytotoxic chemicals, as measured by viable cell
counts, colony-forming ability and proliferative capacity, have been studied using
Chinese hamster cells in exponential and plateau (stationary) phases of growth. The
proliferating cells were altogether more sensitive to the action of the drugs than non-
proliferating cells. However, imuran (azathioprine) a purine antimetabolite, was
more effective against the plateau-phase cells. The observed response of cells to
imuran could be detected at a wide range of concentrations (1-100 ,ug/ml). These
findings are discussed in view of the possible ability of imuran to interfere with
active metabolic processes in non-proliferating cells.
THE main aim of the present investi-
gation was to gain insight into the relation-
ship between the cellular effects of anti-
neoplastic agents and the proliferative
state of the exposed cell population.
There is a general agreement (Wheeler
and Simpson-Herren, 1973; Clarkson,
1974; Valeriote and van Putten, 1975)
that the faster the growth of a cell
population, the greater is the susceptibility
of that population to the cytocidal effects
of antimetabolites. Indeed, numerous
experimental data obtained on various
cell systems definitely showthat proliferat-
ing cells are altogether more sensitive to
cytotoxic agents than resting cells (Bruce,
Meeker and Valeriote, 1966; van Putten,
Lelieveld and Kram-Jdsenga, 1972;
Rajewsky, 1975). Hence, the main way of
destroying non-proliferating cells, accord-
ing to the current schedules (Valeriote,
1975; Valeriote and van Putten, 1975)
consists in their recruitment into the cell
cycle to make them targets for the
appropriate inhibitors.
However, in the course of recent years,
evidence has been collected that, in some
situations, the non-proliferating cells may
reveal an even greater sensitivity to drugs
than proliferating cells (Barranco, Novak
and Humphrey, 1973, 1975; Twentyman
and Bleehen, 1973; Hahn, Gordon and
Kurkjian, 1974; Sutherland, 1974; Tobey
and Crissman, 1975; Tobey, Oka and
Crissman, 1975; see also Marsh, 1976, for
review). Although some of the results
appear to be conflicting, there is no doubt
at present that, at least under certain
conditions, the non-proliferating cells may
be severely damaged by concentrations of
drugs less toxic to the proliferating cells.
In this respect, the search for cytotoxic
agents directly affectingthenon-proliferat-
ing cells may be of great importance for
cancer therapy.
The studies reported here are concerned
with the sensitivity of proliferating and
non-proliferating cells to cytotoxic agents
of different origin. The agents used were
1-/-D-arabinofuranosylcytosine (ara-C),
bleomycin (BLM), daunorubicin (Daun),
distamycin A (DST-A) and imuran (IM).
Ara-C is an antimetabolite that kills cells
byinterfering with DNA synthesis through
inhibition of DNA polymerase (Furth and
Cohen, 1968). BLM is a glycopeptide anti-
biotic arresting cells in the G2 period of
the cell cycle (Tobey, 1972; Watanabe378 0. I. EPIFANOVA, I. N. SMOLENSKAYA AND V. A. POLUNOVSKY
et al., 1974). Daun, an antibiotic of the
anthracycline group, has been showvn to
intercalate into DNA, thus inhibiting
both RNA and DNA synthesis (Di Marco,
Arcamone and Zunino, 1975). DST-A, a
basic oligopeptide antibiotic, exerts the
same effect, acting as an inhibitor of
DNA-dependent nucleic-acid synthesis
(Muiller et al., 1974). IM is a purine anti-
metabolite used as an immunosuppressive
agent (Berenbaum, 1967; Elion and
Hitchings, 1975).
MATERIALS AN'I) METHODS
Cells and cell-culture technique.-Chinese
hamster cells (Strain Blld-ii-FAF 28, Clone
431) grown as monolayers were used. Stock
cultures were maintained in glass bottles in
Eagle nutrient medium supplemented writh
10% bovine serum, 100 u penicillin, and 50 u
streptomycin. Cells were shown to be free of
PPLO by fluorescent microscopy after stain-
ing with acridine orange.
Cell counts and survival determinations. To
study the effects of drugs on cell viability,
cultures were seeded into 15ml Leighton
tubes without coverslips, in 3 ml of medium
and allowed to grow as monolayers. Cells
were trypsinized thereafter (0.25% for 2 min)
and repeatedly pipetted to disperse clumps.
At designated times, aliquots of cell suspen-
sion from 5 tubes wrere counted in a haemo-
cytometer chamber. Ten chambers were used
for each of 5 samples. The counts wvere
corrected for dead cells by microscopic
examination of 200 cells per sample in the
presence of 0410 eosin solution. Viable
cells were defined as cells that were neither
stained nor severely distorted morphologi-
cally. This technique allows one to determine
how many cells are actually killed during
continuous drug exposure.
Survival was determined by the ability of
cells to form colonies (Puck, Cieciura and
Fisher, 1957). This technique has been used
in the present study to check the reproductive
capacity of surviving cells following brief
drug treatment. For these experiments,
known numbers of single cells were plated
into 60mm Petri dishes (- 500 cells per
dish) and incubated at 37°C in an atmos-
phere of 950o air: 500 CO2 for 7 to 9 days.
The pH was measured in the course of
the experiments and maintained between
7-2 and 7 4. The colonies were stained with
30o methylene blue and counted. Five repli-
cate plates wrere used for each survival deter-
mination.
Autoradiogrcaphy and mitotic counts.-For
these investigations, cultures w-ere seeded
into 15ml Leighton tubes on coverslips. To
obtain autoradiographs, cells were pulsed
with 3H-thymidine (3H-TdR) at a concentra-
tion of 1 pQi/ml (sp. act. 5 Ci/mmol) for 30
min before fixing. The coverslips were fixed
in acetic acid-ethanol (1:3) and autoradio-
graphs were obtained using liquid emulsion
of M type (NiiChimPhoto, Moscow) as
described previously (Epifanova et al., 1969).
The labelling index was determined by
counting the 3H-TdR-labelled cells per 1000
cells. Mitotic index was determined from
counting the number of mitoses per 2000
cells in fixed preparations stained with
Mayer's haeinatoxylin. Five samples were
taken for each fixation.
Preparation of cells in exponential and
plateau (stationary) phases of grouth.-Expo-
nentially growing cultures wsere obtained by
seeding 6 x 104 cells per ml. After 48 h of
growth,cellswereused inexperimental studies.
The average population-doubling time in
exponential growth was 16-18 h. To obtain
plateau-phase cultures, cells were allowed to
growr further without medium replenishment.
Cultures wNere considered to be in the early
plateau phase by the 5th-6th days ofgrowth,
when they reached a cell density of 1 .5 x
105/cm2, and at the terminal stage of this
phase by the 10th day of growrth, when a
decrease in cell viability was observed (Eidam
and Merchant, 1965; Hahn et al., 1968).
Drug treatment.-Ara-C (Cytosar) was pur-
chased from the Upjohn s.a., Puurs, Belgium;
BLM was kindly supplied by H. Lundbeck
and Co. A/S, Copenhagen; Daun (Cerubidin)
Avas obtained from Pharma Rhodia, Birkerod,
Denmark; DST-A from Farmitalia Research
Labs, Milan; and IM (azathioprine sodium)
from Burroughs AWlellcome and Co., London.
Drug solutions were prepared immediately
before use to ensure against loss of activity.
All drugs were dissolved in Hanks' balanced
salt solution (HBSS) and then diluted to
final concentrations. The drugs were used at
concentrations exhibiting an optimal effect
in cell-killing studies on cultured Chinese
hamster cells (Barranco et al., 1973, 1975;
Tobey, 1972; Yataganas et al., 1974). The
time and duration of treatment varied,PROLIFERATION-DEPENDENT RESPONSES OF CELLS
depending upon the type of the experiment.
The details will be given in the following
section ofthe paper as required.
RESULTS
A typical growth curve obtained in the
present study is shown in Fig. 1. It
presents an initial lag phase, in which cells
are being attached to the glass surface,
followed by an exponential or log phase,
and finally by a stationary or plateau
phase, in which cell numbers reach
a maximum level of 5 x 105 cells per
ml of culture medium (-' 195 x
105/cm2). The drugs were usually added
to the cultures on the 2nd day after
seeding (to study the sensitivity of expo-
nentially growing cells) and on the 6th
day after seeding (to study the sensitivity
of plateau-phase cells) unless otherwise
indicated. During exponential growth, cell
viability (judged by staining) generally
exceeded 90%. The plateau-phase cul-
tures maintained a high viability (about
75%) up to the 9th day of growth, which
allowed us to investigate the response of
cells to prolonged drug treatment.
i
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E
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FIG. 1. Change in cell number with time after
seeding 6 x 104 cells/ml Chinese hamster
cells in normal culture. Arrows indicate the
points at which the drugs were added. See
text for explanation.
BLM DST-A Daun ARA-C IM
100 10 5 5 103(pUg/ml)
Fie. 2.-Effects ofvarious cytotoxic agents on
number of viable cells in exponentially
growing (C]1) and plateau-phase (U) cells
after 72 h of treatment. The drugs were
added to the cultures on Day 2 (exponential
phase) or on Day 6 (plateau phase) after
plating. Cell counts were made as described
in Materials and Methods. The data are
presented as percentage inhibition ofviable
cells calculated as follows:
Number of Number of
viable cells in - viable cells in
control culture treated culture x 100%
Number of viable cells in control
culture
Bars, ± s.e.
The diagram in Fig. 2 represents the
results ofaviable cell-counting experiment
where cells were continuously incubated
with drugs for 72 h, either in exponential
or in the plateau phase of growth. It can
be seen that growing cells (white columns)
are more sensitive to the action of cyto-
toxic agents than non-growing cells
(shaded columns). Among the examined
drugs, the greatest general cytocidal
effect is shown by Daun, which, under
given conditions, causes a 100% reduction
in number of viable cells in growing
cultures and about 40% in plateau-phase
cultures. In this experiment, our attention
was attracted to IM, which, contrary to
other drugs tested, appeared to be more
effective in killing non-proliferating than
proliferating cells.
We therefore made a cell-counting
experiment to obtain data on the viability
of exponentially growing and plateau-
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Fi(T. 3. Viability of exponentially growing
(0) and plateau-phase (0) cells exposed(
to graded concentrations of IM after 48 h
of treatment. IM was added to the cultures
on Day 2 (exponential phase) or on Day 6
(plateau phase) after plating. Cell counts
were made as described in Materials and
Methods. Bars, ± s.e.
phase cells exposed to graded concentra-
tions of IM. The results ofthis experiment
are given in Fig. 3. Again we can see that
non-proliferating cells are more vulnerable
to IM than proliferating cells, being
affected even at concentrations as low as
1.0 and 10 /g/ml, (i.e. 10- and 100-fold
smaller than that initially tested).
To investigate the question further, we
compared the effects ofIM on cell viability
in the exponential and plateau phases of
growth, performing the cell counts after
a 24- and 48h drug exposure. The data in
Table I summarize the results of 4
experiments which confirm and extend the
previously obtained results showing that
IM kills the non-proliferating cells more
readily than the growing cells. The
observed differences are very pronounced
from the beginning of the experiment. In
Table I are also shown the data obtained
with Daun which, under similar conditions,
exerts a preferential effect on growing
cells.
In the following experiment, we studied
the effects of IM and Daun on the colony-
forming ability of cells treated for 1 h
C IM D C IM D
FI(G. 4. Effects of IDI (100 ,g/ml) an(l
Daun (5 ,ug/ml) on the colony-forming
ability of exponentially growing (A) andl
plateau phase (B) cells. C, control; D, Dausi;
TIM, imnsran. Cells were treated1 with drugs
for 1 h in either exponential or plateau
phase (on Days 2 and 6 of growth, respect-
ively) and plated into Petri dishes imme-
diately after treatment. Bars, + s.e. The
restults represent the average of 3 experi-
ments.
in either exponential or plateau-phase
growth. The results in Fig. 4 show that
cells treated with IM in the exponential
phase (A) reveal a greater survival than
those treated in plateau phase (B). In the
same situation, Daun affects more readily
the colony-forming ability of exponent-
ially growing cells.
The next step was to investigate the
effects of IM on the proliferative capacity
of growing and non-growing cells. The
first experiment on these lines was
designed to examine how IM would
affect the mitotic activity of a growing
cell population during early hours of
treatment. The results in Fig. 5 show
that IM causes only a 150% depression of
the mitotic index, even after a 1Oh
contact with cells. In similar conditions,
Daun completely inhibited the mitotic
activity of growing cells by the 3rd hour
of treatment.
In the following experiment we pro-
longed the exposure of cells to IM up to
24 and 48 h and compared its effects on
the proliferative activity in growing and
plateau-phase cultures. This time we
started the treatment of cells with IM on
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Time of treatment (h)
FIe. 5. Effects of IMI (100 ,ug/ml) an(i Dauiei
(5 ,ug/ml) on the mitotic in(lex in exponeni-
tially growing cells. The (Irugs were added
to the cultures on Day 2 after platinig (zero
time) an(l remainedi irn the medliunm tup to the
endi of the experiment. 0, control; 0,
Daun; 0!, IM. Bars, L s.e. Each point
represenits the mean of 5 samples.
Days 1 and 4 after plating, respectively.
In this way we expected to locate the
changes in the proliferative capacity of
cells during the transition from growing to
non-growing state.
The results in Table II show that, in
control cultures, both the labelling and
mitotic indices are high for the first 5 days
after plating. On Day 6, however, the
labelling index falls to 1.5% and mitotic
index to 8-5 x 10-3. These results co-
incide with the data obtained on mono-
layer cultures of EMT6 mouse tumour
cells (Twentyman and Bleehen, 1975).
As seen in Table II, IM completely
abolishes the DNA-synthetic capacity and
markedly diminishes the mitotic activity
of cells in early plateau phase, affecting
the growing cells far less.
Microscopic examination of cultures
revealed that after 24 h with IM there
were many degenerative metaphases,
whereas most of the interphase cells
appeared normal. However, after 48 h of
treatment almost all cells had degenerated.
DIISCUSSION
The results presented here reveal marked
differences between the effects of cyto-
toxic agents on both cell viability and
proliferative capacity of exponentially
growing and plateau-phase Chinese ham-
ster cells.
Before discussing the observed
reactions of cells, one important point to
be considered concerns the characteristics
of the examined cell culture. Detailed
kinetic analysis of the plateau-phase cells
in a Chinese hamster cell line revealed
their close resemblance to cell-renewal
populations and tumours in vivo (Mauro
et al., 1974a), indicating that a model
system of this type could be particularly
useful for studies of cellular effects of
chemotherapeutic drugs (Barranco et al.,
1973).
TABLE II. Effects of IM (100 Jug/ml) on the Labelling and Mitotic Indices
(mean±s.e.) in Exponentially Growing and Plateau-phase Cells
Time of cell growth (days)
Time after (crug addlition (h)
Treatment Index (mean ± s.e.)
Control Labelling (%)
Mitotic ( x 10-3)
11\1 Labelling (Oo)
Mitotic ( X 10-3)
Exponential phase,
2 :3
24 48
39-4 ± 1-4
29-3 X 3-6
21-:3 + 0-6
22-0 + 1-9
33:0 ± 1-9
28-0 ± 0 4
19-:3 2-9
17-0 ±:3-8
Plateaui phase
5
24
24-6 ± 2-8
22-0 ± 0 4
0-0 X 00
5-6 + 1'9
6
48
1-5 0-5
8-5 + 1-5
(00 0()0
:-5 + 1-0
IM was ad(led to the cultures on Day 1 (exponential phase) or Day 4 (plateau phase) after plating. Cells
wNere continuotusly exposed to the drtug. Each valuie is the mean of 5 samples. Labelling index was determine(d
from counts over 1000 :3H-TdR pulse-labelled cells, mitotic indlex from the number of mitoses in 2000 cells.PROLIFERATION-DEPENDENT RESPONSES OF CELLS
A common way of obtaining plateau-
phase cells in culture is serum deprivation
of the nutrient medium (Pardee, 1974;
Epifanova, Abuladze and Zosimovskaya,
1975; Holley, 1975). However, we deliber-
ately avoided this procedure because of
the conflicting results obtained on pro-
liferating and non-proliferating Chinese
hamster cells with drugs dissolved in
either BSS or serum-supplemented med-
ium (Barranco et al., 1973; Hahn et al.,
1974). Another reason for avoiding
serum control is that cells chronically
deprived of serum become more sensitive
to toxic factors (Hahn, 1974). For similar
reasons, we did not induce cell quiescence
by other kinds of nutrient starvation,
since each of these factors alters the
physiological state of cells in its own
peculiar way, making the results non-
comparable (Kohn, 1975). We therefore
preferred to obtain the plateau-phase
population by allowing cells to grow for
several days without medium replenish-
ment. Although cells under such condi-
tions may change the medium to some
extent by the products oftheir decay, this
cannot account for theirdifferent responses
to the drugs in comparison with the
exponentially growing cells.
A large body of experimental and
clinical data indicates a greater sensitivity
of proliferating cells than non-proliferat-
ing cells to antitumour agents (see
Valeriote and van Putten, 1975 for
review). At the same time there are
indications (Steel, 1970; Valeriote, 1975)
that for most solid tumours the non-
proliferating (Go) cell population may be
of a significant size. It is accepted there-
fore that optimal therapy for tumours
with a Go cell population requires recruit-
ment of these cells into a proliferative
state where they can be killed more
effectively by anticancer agents. This
does not exclude, however, the possibility
of attacking the non-proliferating cells
directly.
Indeed, some of the investigated com-
pounds have been reported to damage the
non-proliferating cells even more effect-
ively than proliferating cells (Barranco
et al., 1973, 1975; Twentyman and
Bleehen, 1973; Sutherland, 1974; Tobey
and Crissman, 1975; Tobey et al., 1975;
Bhuyan et al., 1977). In accordance
with these data, we have shown that
IM, a purine antimetabolite with im-
munosuppresive properties, is especially
effective in killing plateau-phase cells.
Moreover, IM causes less than 50%0
depression of the labelling and mitotic
indices in growing cells, even after a 48h
treatment. However, when cells reach the
early plateau phase (5 days of growth)
where the mitotic and labelling indices
are still high, they reveal a much greater
sensitivity to IM, which completely sup-
presses the proliferative activity after a
24h contact with cells.
The mechanism whereby IM differ-
entially affects the growing and non-
growing cells is unclear. The inhibitory
action of IM on proliferative activity may
be connected with the ability of cells to
convert IM into 6-mercaptopurine (6-MP)
which is the active metabolite of IM
within a cell, blocking the pathways of
DNA and RNA synthesis. As previously
noted (Gonzalez et at., 1970; Malamud
et al., 1972) IM depresses DNA synthesis
and cell reproduction in normal and
regenerating liver and other organs of
rats. However, this can hardly be the
cause of preferential cytotoxic action of
IM on non-growing cells, since DNA
synthesis proceeds in these cells at a very
low level.
One plausible explanation of the effects
of IM on resting cells is connected with
the ability of 6-MP released from IM to
prevent the conversion of hypoxanthine
to xanthine, while inhibiting xanthine
oxidase (Silberman and Wyngarden, 1961).
This may result in a general depression of
catabolic pathways of purines in resting
cells. According to current knowledge (see
Epifanova, 1977 for review) resting cells
are characterized by a marked increase
in the activity of catabolic enzymes,
including those catabolizing purine and
pyrimidine nucleosides. IM depresses the
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pyrimidine nucleosides. We suggest, there-
fore, that IM depresses the catabolic
pathways of purines in resting cells and,
consequently, their viability.
Another reason for a higher sensitivity
of resting cells to IM may lie in their
ability to degrade more readily the newly
formed rRNA molecules (Cooper, 1972;
Abelson et al., 1974). In this case IM (or
its active principle, 6-MP), acting as an
antipurine metabolite, may decrease the
rate of ribosome production, thereby
suppressing protein synthesis and bringing
about cell death.
There are indications (Barranco et al.,
1973; Hahn et al., 1974) that BLM, like
IM, kills non-proliferating cells more
readily. In the present study we did not,
however, detect any preferential effects of
BLM on plateau-phase cells. On the
contrary, they were far more resistant to
the action of the drug than growing cells,
which confirms the data of other authors
(Twentyman and Bleehen, 1973; Mauro
et al., 1974b; Briganti et al., 1975). A
possible explanation for the observed
differences lies in the length of time the
cells had been in the plateau phase when
the studies were performed. Cultures in
early plateau-phase show a lower sensitiv-
ity to BLM than those in exponential
growth. However, after a longer period in
plateau phase the sensitivity becomes
greater than that ofgrowing cells (Twenty-
man and Bleehen, 1975).
It is essential that we know more about
the mechanisms maintaining cells in
resting phase, in order to pursue the
question of cell response as a function of
the proliferative state. Yet the detection
of active metabolic processes in resting
cells outlines a possible way in which such
cells may be affected without their pre-
liminary recruitment into the cell cycle.
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